Childhood cancer survivorship research in minority populations: A position paper from the childhood cancer survivor study

Smita Bhatia, Todd M. Gibson, Kirsten K. Ness, Qi Liu, Kevin C. Oeffinger, Kevin R. Krull, Paul C. Nathan, Joseph P. Neglia, Wendy Leisenring, Yutaka Yasui, Leslie L. Robison, Gregory T. Armstrong

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

By the middle of this century, racial/ethnic minority populations will collectively constitute 50% of the US population. This temporal shift in the racial/ethnic make-up of the US population demands a close look at the race/ethnicity-specific burden of morbidity and premature mortality among childhood cancer survivors. To optimize targeted long-term follow-up care, it is essential to understand whether the burden of morbidity borne by survivors of childhood cancer differs by race/ethnicity. This is challenging because the number of minority participants is often limited in current childhood cancer survivorship research, resulting in a paucity of race/ethnicity-specific recommendations and/or interventions. We show that while the overall childhood cancer incidence increased between 1973 and 2003, the mortality rate declined; however these changes did not differ appreciably by race/ethnicity. We speculate that any racial/ethnic differences in outcome are likely to be multifactorial, and draw upon data from the Childhood Cancer Survivor Study to illustrate the various contributors (socioeconomic characteristics, health behaviors and comorbidities) that could explain any observed differences in key treatment-related complications. Finally, we outline challenges in conducting race/ethnicity-specific childhood cancer survivorship research, showing that there are limited absolute numbers of children who are diagnosed and survive cancer in any one racial/ethnic minority population, precluding a rigorous evaluation of adverse events among specific primary cancer diagnoses and treatment exposure groups.

Original languageEnglish (US)
JournalCancer
Volume122
Issue number15
DOIs
StatePublished - Jan 1 2016

Fingerprint

Survivors
Survival Rate
Research
Population
Neoplasms
Morbidity
Aftercare
Premature Mortality
Health Behavior
Comorbidity
Mortality
Incidence
Therapeutics

Cite this

Bhatia, S., Gibson, T. M., Ness, K. K., Liu, Q., Oeffinger, K. C., Krull, K. R., ... Armstrong, G. T. (2016). Childhood cancer survivorship research in minority populations: A position paper from the childhood cancer survivor study. Cancer, 122(15). https://doi.org/10.1002/cncr.30072

Childhood cancer survivorship research in minority populations : A position paper from the childhood cancer survivor study. / Bhatia, Smita; Gibson, Todd M.; Ness, Kirsten K.; Liu, Qi; Oeffinger, Kevin C.; Krull, Kevin R.; Nathan, Paul C.; Neglia, Joseph P.; Leisenring, Wendy; Yasui, Yutaka; Robison, Leslie L.; Armstrong, Gregory T.

In: Cancer, Vol. 122, No. 15, 01.01.2016.

Research output: Contribution to journalArticle

Bhatia, S, Gibson, TM, Ness, KK, Liu, Q, Oeffinger, KC, Krull, KR, Nathan, PC, Neglia, JP, Leisenring, W, Yasui, Y, Robison, LL & Armstrong, GT 2016, 'Childhood cancer survivorship research in minority populations: A position paper from the childhood cancer survivor study', Cancer, vol. 122, no. 15. https://doi.org/10.1002/cncr.30072
Bhatia, Smita ; Gibson, Todd M. ; Ness, Kirsten K. ; Liu, Qi ; Oeffinger, Kevin C. ; Krull, Kevin R. ; Nathan, Paul C. ; Neglia, Joseph P. ; Leisenring, Wendy ; Yasui, Yutaka ; Robison, Leslie L. ; Armstrong, Gregory T. / Childhood cancer survivorship research in minority populations : A position paper from the childhood cancer survivor study. In: Cancer. 2016 ; Vol. 122, No. 15.
@article{1682065f98f8478e90e0db9c6759f35d,
title = "Childhood cancer survivorship research in minority populations: A position paper from the childhood cancer survivor study",
abstract = "By the middle of this century, racial/ethnic minority populations will collectively constitute 50{\%} of the US population. This temporal shift in the racial/ethnic make-up of the US population demands a close look at the race/ethnicity-specific burden of morbidity and premature mortality among childhood cancer survivors. To optimize targeted long-term follow-up care, it is essential to understand whether the burden of morbidity borne by survivors of childhood cancer differs by race/ethnicity. This is challenging because the number of minority participants is often limited in current childhood cancer survivorship research, resulting in a paucity of race/ethnicity-specific recommendations and/or interventions. We show that while the overall childhood cancer incidence increased between 1973 and 2003, the mortality rate declined; however these changes did not differ appreciably by race/ethnicity. We speculate that any racial/ethnic differences in outcome are likely to be multifactorial, and draw upon data from the Childhood Cancer Survivor Study to illustrate the various contributors (socioeconomic characteristics, health behaviors and comorbidities) that could explain any observed differences in key treatment-related complications. Finally, we outline challenges in conducting race/ethnicity-specific childhood cancer survivorship research, showing that there are limited absolute numbers of children who are diagnosed and survive cancer in any one racial/ethnic minority population, precluding a rigorous evaluation of adverse events among specific primary cancer diagnoses and treatment exposure groups.",
author = "Smita Bhatia and Gibson, {Todd M.} and Ness, {Kirsten K.} and Qi Liu and Oeffinger, {Kevin C.} and Krull, {Kevin R.} and Nathan, {Paul C.} and Neglia, {Joseph P.} and Wendy Leisenring and Yutaka Yasui and Robison, {Leslie L.} and Armstrong, {Gregory T.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1002/cncr.30072",
language = "English (US)",
volume = "122",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "15",

}

TY - JOUR

T1 - Childhood cancer survivorship research in minority populations

T2 - A position paper from the childhood cancer survivor study

AU - Bhatia, Smita

AU - Gibson, Todd M.

AU - Ness, Kirsten K.

AU - Liu, Qi

AU - Oeffinger, Kevin C.

AU - Krull, Kevin R.

AU - Nathan, Paul C.

AU - Neglia, Joseph P.

AU - Leisenring, Wendy

AU - Yasui, Yutaka

AU - Robison, Leslie L.

AU - Armstrong, Gregory T.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - By the middle of this century, racial/ethnic minority populations will collectively constitute 50% of the US population. This temporal shift in the racial/ethnic make-up of the US population demands a close look at the race/ethnicity-specific burden of morbidity and premature mortality among childhood cancer survivors. To optimize targeted long-term follow-up care, it is essential to understand whether the burden of morbidity borne by survivors of childhood cancer differs by race/ethnicity. This is challenging because the number of minority participants is often limited in current childhood cancer survivorship research, resulting in a paucity of race/ethnicity-specific recommendations and/or interventions. We show that while the overall childhood cancer incidence increased between 1973 and 2003, the mortality rate declined; however these changes did not differ appreciably by race/ethnicity. We speculate that any racial/ethnic differences in outcome are likely to be multifactorial, and draw upon data from the Childhood Cancer Survivor Study to illustrate the various contributors (socioeconomic characteristics, health behaviors and comorbidities) that could explain any observed differences in key treatment-related complications. Finally, we outline challenges in conducting race/ethnicity-specific childhood cancer survivorship research, showing that there are limited absolute numbers of children who are diagnosed and survive cancer in any one racial/ethnic minority population, precluding a rigorous evaluation of adverse events among specific primary cancer diagnoses and treatment exposure groups.

AB - By the middle of this century, racial/ethnic minority populations will collectively constitute 50% of the US population. This temporal shift in the racial/ethnic make-up of the US population demands a close look at the race/ethnicity-specific burden of morbidity and premature mortality among childhood cancer survivors. To optimize targeted long-term follow-up care, it is essential to understand whether the burden of morbidity borne by survivors of childhood cancer differs by race/ethnicity. This is challenging because the number of minority participants is often limited in current childhood cancer survivorship research, resulting in a paucity of race/ethnicity-specific recommendations and/or interventions. We show that while the overall childhood cancer incidence increased between 1973 and 2003, the mortality rate declined; however these changes did not differ appreciably by race/ethnicity. We speculate that any racial/ethnic differences in outcome are likely to be multifactorial, and draw upon data from the Childhood Cancer Survivor Study to illustrate the various contributors (socioeconomic characteristics, health behaviors and comorbidities) that could explain any observed differences in key treatment-related complications. Finally, we outline challenges in conducting race/ethnicity-specific childhood cancer survivorship research, showing that there are limited absolute numbers of children who are diagnosed and survive cancer in any one racial/ethnic minority population, precluding a rigorous evaluation of adverse events among specific primary cancer diagnoses and treatment exposure groups.

UR - http://www.scopus.com/inward/record.url?scp=84995584851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995584851&partnerID=8YFLogxK

U2 - 10.1002/cncr.30072

DO - 10.1002/cncr.30072

M3 - Article

C2 - 27253866

AN - SCOPUS:84995584851

VL - 122

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 15

ER -